Breast Cancer

Phase 1 Study Of Breast Cancer Vaccine Present Positive Data

Positive results from the Phase 1 clinical trial of a breast cancer vaccine were announced by Anixa Biosciences and Cleveland Clinic, with hopes of FDA approval to distribute the vaccine to the public after Phase 2 and 3 trials are